Toxicology News and Research

Latest Toxicology News and Research

BioCryst Pharmaceuticals announces fourth-quarter and full-year 2009 financial results

BioCryst Pharmaceuticals, Inc. today announced financial results for the fourth quarter and year ended December 31, 2009.

4 Feb 2010

Wolters Kluwer Health relaunches flagship drug information reference as Facts & Comparisons eAnswers

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that it has relaunched its flagship drug information reference as Facts & Comparisons® eAnswers.

4 Feb 2010

ACT and Brown Cancer Center scientist collaborate in discovery of new therapeutics for cancer

Advanced Cancer Therapeutics (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that it has signed an agreement to leverage the computational chemistry expertise of Dr. John Trent, Associate Professor, Department of Medicine at the University of Louisville’s James Graham Brown Cancer Center (Brown Cancer Center), to accelerate the identification of new clinical candidates for the prevention and treatment of cancer.

4 Feb 2010

Entelos awarded U.S. patent for apparatus and methods of assessing metabolic substrate utilization

Entelos, Inc., a simulation and modeling company focused on human health, announced today that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,654,955 entitled “Apparatus and Methods for Assessing Metabolic Substrate Utilization” to the Company. These methods further strengthen the Entelos® Metabolism PhysioLab® platform and leverage insights about human physiology that can lead to improved diagnosis, clinical testing, and personalized treatment across a highly variable patient population.

2 Feb 2010

Scientists and engineers conduct research on environmental health impacts of nanomaterials

As researchers around the world hasten to employ nanotechnology to improve production methods for applications that range from manufacturing materials to creating new pharmaceutical drugs, a separate but equally compelling challenge exists.

2 Feb 2010

Millennium Laboratories supports CLIA certification for Florida clinical laboratories

Millennium Laboratories, Inc., a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain patients, today announced the company’s support for a recent decision by the Florida Pain Management Clinic Standards of Practice Joint Committee to amend draft regulatory language related to the certification of clinical laboratories providing services to pain physicians operating in the state.

2 Feb 2010

Hormones & Cancer: A new journal from The Endocrine Society

Today, The Endocrine Society unveiled its newest journal, Hormones & Cancer. This bi-monthly journal will include research articles covering all aspects of hormone action on cancer causation, progression, dependence, prevention, resistance and treatment.

29 Jan 2010

St. Joseph's Regional Medical Center opens Geriatric ED to treat senior patients

St. Joseph's Regional Medical Center, Paterson, NJ, recently opened the region's first dedicated Geriatric Emergency Department (Geriatric ED). Treating patients age 65 and older, the department is designed to meet the complex needs of older patients in a senior-friendly environment.

27 Jan 2010

Jubilant Biosys, Endo Pharmaceuticals expand their drug discovery partnership in oncology

Jubilant Biosys Ltd., a subsidiary of Jubilant Organosys Ltd., and Endo Pharmaceuticals ( ENDP)., of Chadds Ford, Pa., U.S.A., announced today that they have expanded their drug discovery partnership in oncology, following the successful delivery of an early stage milestone.

27 Jan 2010

Microbia's beta-carotene receives 'GRAS' status for food and beverage applications

Microbia, Inc., today announced that a panel of independent experts has determined its bio-based β-carotene (beta-carotene) to be GRAS (Generally Recognized As Safe) for both food and beverage applications.

27 Jan 2010

Progress in Anadys Pharmaceuticals' Phase II study of ANA598 announced

Anadys Pharmaceuticals, Inc. today announced that ANA598 dosing has been completed in the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients.

22 Jan 2010

FDA accepts ACT Biotech's ACTB1003 IND

ACT Biotech Inc., a privately held biotechnology company developing a portfolio of oral kinase inhibitors as anti-cancer drugs, today announced the acceptance of the Investigational New Drug (IND) application for ACTB1003 by the US Food and Drug Administration (FDA). The company has now assembled a complete preclinical package, including manufacturing and toxicology studies, allowing ACTB1003 to enter a clinical trial.

22 Jan 2010

BioLife Solutions announces biologic packaging products pre-filled with GMP biopreservation media

BioLife Solutions, Inc., a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, and OriGen Biomedical, a leading provider of biologic packaging products for research and clinical blood and cell-based therapies, today announced that the companies will introduce sterile standard and custom biologic packaging products pre-filled with BioLife's serum-free, protein-free HypoThermosol® cell and tissue storage/transport media and CryoStor™ cryopreservation media.

21 Jan 2010

Simulations Plus board authorizes renewed share repurchase program

Simulations Plus, Inc., the leading provider of simulation and modeling software for pharmaceutical discovery and development, announced today that its board of directors has authorized a renewed share repurchase program effective Monday, February 15, 2010.

21 Jan 2010

High intake of iron and copper can contribute to age-related disorders in older adults

With scientific evidence linking high levels of copper and iron to Alzheimer's disease, heart disease, and other age-related disorders, a new report in ACS' Chemical Research in Toxicology suggests specific steps that older consumers can take to avoid build up of unhealthy amounts of these metals in their bodies.

21 Jan 2010

AMRI’s Rensselaer labs and manufacturing facilities receive SafeBridge Potent Compound Safety Certification

SAFEBRIDGE® CONSULTANTS, INC., headquartered in Mountain View, California, has announced that AMRI’s high potency research laboratories and GMP-manufacturing facilities in Rensselaer, New York have met the criteria established under the SafeBridge program for “Potent Compound Safety Certification” and have been deemed competent and proficient in the safe handling of potent active pharmaceutical ingredients (“APIs”).

20 Jan 2010

Babraham Institute research may lead to new means of making purified T cells

Research from the Babraham Institute, reported today in the Journal of Experimental Medicine, provides new insights into how our immune system produces T cells, a type of white blood cell that is an essential part of the body's immune surveillance system for fighting infection. The findings pave the way for a new means of making purified T cells, which gets over one of many hurdles faced in the use of T cells in regenerative medicine and transplantations, and in addition will open up new avenues of research and applications in drug and toxicity testing in industry.

18 Jan 2010

Metabolon awarded US Patent for ‘metabolomics methods’

Metabolon, Inc., the leader in global metabolism through biomarker discovery and analysis, today announced that it was awarded US Patent 7,635,556 “Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics” by the United States Patent and Trademark Office on December 22, 2009.

18 Jan 2010

Environmental health groups call for ban on BPA from all food applications

Environmental health advocates responded to today's announcement that Food and Drug Administration concurs with the National Toxicology Program's assessment that bisphenol A is a chemical of concern. FDA posted tips for parents to minimize children's exposure, and announced further research. BPA is a synthetic sex hormone linked to cancer, behavioral changes, reproductive harm, heart problems and other illnesses.

18 Jan 2010

FDA admits concern, but does not ban BPA: Consumers Union disappointed

Consumers Union, the nonprofit publisher of Consumer Reports, expressed disappointment with the U.S. Food & Drug Administration's (FDA) failure to ban the chemical bisphenol A (BPA), despite announcing today that there is cause for concern over its potential effect on children. Consumers Union believes that that there is enough scientific evidence to date to warrant a ban on BPA in food contact products now.

18 Jan 2010

Toxicology News and Research

Latest Toxicology News and Research

BioCryst Pharmaceuticals announces fourth-quarter and full-year 2009 financial results

Wolters Kluwer Health relaunches flagship drug information reference as Facts & Comparisons eAnswers

ACT and Brown Cancer Center scientist collaborate in discovery of new therapeutics for cancer

Entelos awarded U.S. patent for apparatus and methods of assessing metabolic substrate utilization

Scientists and engineers conduct research on environmental health impacts of nanomaterials

Millennium Laboratories supports CLIA certification for Florida clinical laboratories

Hormones & Cancer: A new journal from The Endocrine Society

St. Joseph's Regional Medical Center opens Geriatric ED to treat senior patients

Jubilant Biosys, Endo Pharmaceuticals expand their drug discovery partnership in oncology

Microbia's beta-carotene receives 'GRAS' status for food and beverage applications

Progress in Anadys Pharmaceuticals' Phase II study of ANA598 announced

FDA accepts ACT Biotech's ACTB1003 IND

BioLife Solutions announces biologic packaging products pre-filled with GMP biopreservation media

Simulations Plus board authorizes renewed share repurchase program

High intake of iron and copper can contribute to age-related disorders in older adults

AMRI’s Rensselaer labs and manufacturing facilities receive SafeBridge Potent Compound Safety Certification

Babraham Institute research may lead to new means of making purified T cells

Metabolon awarded US Patent for ‘metabolomics methods’

Environmental health groups call for ban on BPA from all food applications

FDA admits concern, but does not ban BPA: Consumers Union disappointed

Forensics And Toxicology eBook

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Toxicology News and Research

Latest Toxicology News and Research

Forensics And Toxicology eBook

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in